EricS.SandlerMD

Pediatric Hematology & Oncology • Jacksonville, FL

Chief, Hematology/ Oncology Nemours Children's Clinic

Join to view full profile

Dr. Sandler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sandler's full profile

Already have an account?

Office
807 Childrens Way
Jacksonville, FL 32207
Phone+1 904-697-3600

Fax+1 904-697-3793
Is this information wrong?

Education & Training

University of FloridaFellowship, Pediatric Hematology/Oncology, 1988 - 1991
University of California (San Francisco)Residency, Pediatrics, 1985 - 1988
University of Vermont College of MedicineClass of 1985

Certifications & Licensure

FL State Medical License 1988 - 2025
GA State Medical License 2014 - 2024
TX State Medical License 1991 - 2000
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
Completed
Phase 2
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 1, Phase 2
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Start of enrollment: 2007 Jan 01
Completed
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia Start of enrollment: 2008 Jan 01
Completed
Phase 2
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2008 Dec 08
Active, not recruiting
Phase 3
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Start of enrollment: 2008 Apr 01
Completed
Phase 2
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers Start of enrollment: 2008 Jun 02
Completed
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Start of enrollment: 2008 Jun 23
Completed
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Start of enrollment: 2010 Jun 01
Terminated
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
Terminated
Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Start of enrollment: 2011 May 01
Completed
Not Applicable
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma Start of enrollment: 2012 Jan 01
Completed
Phase 2
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
Completed
Phase 1
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
Completed
Phase 1
Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Start of enrollment: 2013 Oct 01
Withdrawn
Phase 2
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy Start of enrollment: 2013 Dec 04
Active, not recruiting
Phase 2
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicen...
Marinka L F Hol, Daniel J Indelicato, Olga Slater, Frederic Kolb, Richard J Hewitt, Juling Ong, Alfred G Becking, Jenny Gains, Julie Bradley, Eric Sandler, Mark N Gaze...> ;Pediatric Blood & Cancer. 2023 Aug 1
7 citations
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
Craig Erker, Martin Mynarek, Simon Bailey, Claire M Mazewski, Lorena Baroni, Maura Massimino, Juliette Hukin, Dolly Aguilera, Andrea M Cappellano, Vijay Ramaswamy, Alv...> ;Journal of Clinical Oncology. 2023 Apr 1
1 citations
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tum...
Jonathan L Metts, Matteo Trucco, Daniel A Weiser, Patrick Thompson, Eric Sandler, Tiffany Smith, Jessica Crimella, Samer Sansil, Ram Thapa, Brooke L Fridley, Nicholas ...> ;Cancer Medicine. 2023 Feb 1
7 citations
Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry.
Margot A Lazow, Christine E. Fuller, Mariko DeWire, Adam Lane, Pratiti Bandopadhayay, Ute Bartels, Eric Bouffet, Sylvia Cheng, Kenneth J. Cohen, Tabitha Cooney, Scott ...> ;Neuro-Oncology. 2021 Oct 20
Long-term outcomes of pediatric and young adult patients receiving radiotherapy for nonmalignant vascular anomalies.
Kevin X. Liu, Nayan Lamba, Karen J. Marcus, Eric Sandler, Stuart H. Gold, Judith F. Margolin, Daphne A. Haas-Kogan, Denise M. Adams> ;Pediatric Blood & Cancer. 2021 Mar 23
1 citations
Outcomes following limited‐volume proton therapy for multifocal spinal myxopapillary ependymoma
Wen Shen Looi, Daniel J. Indelicato, Raymond B. Mailhot Vega, Christopher G. Morris, Eric Sandler, Philipp R. Aldana, Julie A. Bradley> ;Pediatric Blood & Cancer. 2021 Mar 1
19 citations
Second tumor risk in children treated with proton therapy
Daniel J. Indelicato, James E. Bates, Raymond B. Mailhot Vega, Ronny L Rotondo, Bradford S. Hoppe, Christopher G. Morris, Wen S. Looi, Eric Sandler, Philipp R. Aldana,...> ;Pediatric Blood & Cancer. 2021 Feb 9
Simultaneous Diagnosis of Craniopharyngioma in 2 Brothers.
I-Chia Liu, Daniel J. Indelicato, Julie A. Bradley, Raymond B. Mailhot Vega, Eric Sandler, Philipp R. Aldana> ;Journal of Pediatric Hematology/oncology. 2020 Dec 14
7 citations
Local Control After Proton Therapy for Pediatric Chordoma.
Daniel J. Indelicato, Ronny L Rotondo, Raymond B. Mailhot Vega, Adam L. Holtzman, Wen S. Looi, Christopher G. Morris, Eric Sandler, Philipp R. Aldana, Julie A. Bradley> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Apr 1
6 citations
Surveillance imaging in pediatric ependymoma.
Darren Klawinski, Daniel J. Indelicato, Jobayer Hossain, Eric Sandler> ;Pediatric Blood & Cancer. 2020 Aug 3
9 citations
Implementation of family psychosocial risk assessment in pediatric cancer with the Psychosocial Assessment Tool (PAT): study protocol for a cluster-randomized comparat...
Anne E Kazak, Janet A. Deatrick, Michele A. Scialla, Eric Sandler, Rebecca E Madden, Lamia P. Barakat> ;Implementation Science. 2020 Jul 29
8 citations
Patterns of Failure in Parameningeal Alveolar Rhabdomyosarcoma.
Julie A. Bradley, Daniel J. Indelicato, Haruka Uezono, Christopher G. Morris, Eric Sandler, Hernando de Soto, Raymond B. Mailhot Vega, Ronny L. Rotondo> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Jun 1
1 citations
Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
Bradford S. Hoppe, Raymond B. Mailhot Vega, Nancy P. Mendenhall, Eric Sandler, William B. Slayton, Howard M. Katzenstein, Michael Joyce, Zuofeng Li, S. Flampouri> ;International Journal of Particle Therapy. 2020 Mar 1
8 citations
Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.
Shivam M Kharod, Daniel J. Indelicato, Ronny L. Rotondo, Raymond B. Mailhot Vega, Haruka Uezono, C.G. Morris, Scott Bradfield, Eric Sandler, Julie A. Bradley> ;Pediatric Blood & Cancer. 2020 Feb 1
3 citations
Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma.
Marinka L.F. Hol, Daniel J. Indelicato, Ronny L. Rotondo, Raymond B. Mailhot Vega, Haruka Uezono, Natalie A. Lockney, Eric Sandler, Julie A. Bradley> ;Practical Radiation Oncology. 2020 Jan 1
7 citations
Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.
Haruka Uezono, Daniel J. Indelicato, Ronny L. Rotondo, Eric Sandler, Howard M. Katzenstein, Roi Dagan, William M. Mendenhall, Raymond B. Mailhot Vega, Bernadette Brenn...> ;Pediatric Blood & Cancer. 2019 Sep 16
4 citations
Enteral Nutrition in Pediatric High-risk Head and Neck Cancer Patients Receiving Proton Therapy: Identifying Risk Factors and Quality of Life Concerns to Optimize Care
Allison S Bechtel, Daniel J. Indelicato, Eric Sandler> ;Journal of Pediatric Hematology/oncology. 2019 May 1
71 citations
Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Daniel J. Indelicato, Ronny L. Rotondo, Haruka Uezono, Eric Sandler, Philipp R. Aldana, Nathan J. Ranalli, Alexandra D Beier, Christopher G. Morris, Julie A. Bradley> ;International Journal of Radiation Oncology, Biology, Physics. 2019 May 1
70 citations
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma
Nalin Gupta, Liliana Goumnerova, Peter E. Manley, Susan N. Chi, Donna Neuberg, Maneka Puligandla, Jason Fangusaro, Stewart Goldman, Tadanori Tomita, Tord D. Alden, Art...> ;Neuro-Oncology. 2018 Oct 9
8 citations
Characteristics of Patients ≥ 10 Years of Age with Diffuse Intrinsic Pontine Glioma: A Report from the International DIPG Registry.
Craig Erker, Adam Lane, Brooklyn Chaney, Nancy Yanez Escorza, Christine Fuller, Raya Saab, Mark W. Kieran, Roger J. Packer, Javad Nazarian, Jane E. Minturn, Andrew Dod...> ;Neuro-Oncology. 2018 Jun 22
11 citations
Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Meriem Mokhtech, Ronny L. Rotondo, Julie A. Bradley, Eric Sandler, Ronica H. Nanda, Natalie Logie, Philipp R. Aldana, Christopher G. Morris, Daniel J. Indelicato> ;Pediatric Blood & Cancer. 2018 Jun 1
61 citations
Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States.
Michele A. Scialla, Kimberly S. Canter, Fang Fang Chen, E. Anders Kolb, Eric Sandler, Lori Wiener, Anne E. Kazak> ;Pediatric Blood & Cancer. 2018 Mar 1
45 citations
Outcomes following proton therapy for pediatric ependymoma.
Daniel J. Indelicato, Julie A. Bradley, Ronny L. Rotondo, Ronica H. Nanda, Natalie Logie, Eric Sandler, Philipp R. Aldana, Nathan J. Ranalli, Alexandra D Beier, Christ...> ;Acta Oncologica. 2017 Dec 14
25 citations
Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas.
Daniel J. Indelicato, Julie A. Bradley, Eric Sandler, Philipp R. Aldana, Amy Sapp, Jennifer E. Gains, Adrian Crellin, Ronny L. Rotondo> ;Pediatric Blood & Cancer. 2017 Dec 1
47 citations
Implementing the psychosocial standards in pediatric cancer: Current staffing and services available.
Michele A. Scialla, Kimberly S. Canter, Fang Fang Chen, E. Anders Kolb, Eric Sandler, Lori Wiener, Anne E. Kazak> ;Pediatric Blood & Cancer. 2017 May 19
Join now to see all

Press Mentions

Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer with the Psychosocial Assessment Tool (PAT): Study Protocol for a Cluster-Randomized Comparative Effectiveness TrialJuly 29th, 2020
Learn Why It's Important to Educate Yourself About Childhood Cancer and Treatment Options (FCL September 30th)September 30th, 2019
Why Are Kids in Waycross Getting Cancer?October 20th, 2016